Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Case Report
Case Series
Editorial
Original Article
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Case Report
Case Series
Editorial
Original Article
View/Download PDF

Translate this page into:

Original Article
13 (
2
); 81-88

Comparison of Dexmedetomidine, Lignocaine, and their combination in attenuation of cardiovascular responses to tracheal extubation in controlled hypertensive patients

Assistant professor, Department of Anaesthesia, B.J. Medical College & Civil Hospital, Ahmedabad
Resident, Department of Anaesthesia, B.J. Medical College & Civil Hospital, Ahmedabad
Professor, Department of Anaesthesia, B.J. Medical College & Civil Hospital, Ahmedabad

*Corresponding Author: Dr. Hardul V. Modi Email: hardul@gmail.com

Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

Abstract

Background & Aims:

Tracheal extubation is associated with acute, transient, significant and undesirable hemodynamic and airway responses that may persist into the recovery period. This study was designed to compare the efficacy of dexmedetomidine plus lignocaine with each drug alone in suppressing the hemodynamic changes during extubation in controlled hypertensive patients in elective ENT surgeries.

Material and Method:

In this double-blind randomized study 80 adult patients of age 18 years to 60 years of either sex belonging to ASA grade II having SBP >160 mmhg and/ or DBP >90 mmhg prior on preoperative visit undergoing elective ENT surgeries were randomly divided into 4 groups: Group D received dexmedetomidine [0.1 meg/ kg] iv, Group L received Lignocaine [1mg/kg] iv, Group D+L received Dexmedetomidine [0.1 mcg/kg] iv+ Lignocaine [lmg/kg] iv and Group C received Normal Saline iv before reversal. Hemodynamic parameters in form of heart rate, systolic and diastolic blood pressure, mean arterial pressure, rate pressure product, oxygen saturation was recorded at 1,2,3,5,10 min after extubation. Any side effects during study were noted.

Results:

It was found that heart rate, mean arterial pressure, rate pressure product increased temporarily after tracheal extubation in patients receiving Lignocaine. However, these hemodynamic responses were completely inhibited in those receiving Dexmedetomidine plus lignocaine, but suppressed to some extent with Dexmedetomidine group alone.

Conclusions:

Dexmedetomidine plus lignocaine is an effective and safe prophylaxis for attenuating the cardiovascular responses to tracheal extubation in hypertensive patients and is superior to each drug alone. Dexmedetomidine done suppressed the hemodynamic variables and airway reflexes comparable to combination group.

Keywords

Dexmedetomidine
lignocaine
tracheal extubation
hypertensive patients

Fulltext Views
4

PDF downloads
0
View/Download PDF
Download Citations
BibTeX
RIS
Show Sections